Peptide

Cortagen

Also known as

AEDP · Ala-Glu-Asp-Pro · H-Ala-Glu-Asp-Pro-OH · AEDP peptide · AEDP tetrapeptide · cortex bioregulator · Cortagen peptide · cortex tetrapeptide · cerebral-cortex tetrapeptide · Khavinson Cortagen · Cortexin synthetic analog (AEDP) · SCHEMBL5491754 (database synonym, vendor listings)

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Synthetic AEDP peptide	A four-amino-acid peptide discussed for clearer thinking, mental stamina and nerve recovery. It is distinct from the Cortexin peptide mixture.
Bioregulator idea	The label refers to proposed tissue signaling; it does not establish cortex targeting, permanent brain repair or protection during stimulant or steroid use.

Notes

Cortagen is the synthetic four-amino-acid peptide AEDP, discussed for clearer thinking, mental stamina and nerve recovery. Reports range from easier word retrieval to little benefit or pronounced sleepiness. Animal research helps explain the interest, but does not establish a human treatment or a dependable course.

A defined peptide, different from Cortexin. AEDP joins alanine, glutamate, aspartate and proline in sequence. Cortexin is a peptide mixture; Cortagen is one synthetic sequence developed from that extract research. Extract clinical stories do not establish AEDP results. Adriani et al.: Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice (Animal context · Accessed 2026-09-30)

“Bioregulator” describes the proposed idea. Discussion frames it as gradual tissue signaling. This does not prove cortex targeting, permanent brain repair or protection during stimulant or anabolic-steroid use.

Source context — Adriani et al.: Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice: Mouse behavior; dose-dependent anxiety findings in abstract complicate blanket reassurance. Neither human side-effect rates nor route equivalence; no Cortagen human cognition trial.

What people notice

Thinking and stamina	Accounts describe quieter mental noise, focus and stress composure. One visual-snow reviewer found easier word retrieval but little visual improvement.
Sleepiness or no change	One first-use poster slept much of the day during a roughly five-day course; other accounts describe unchanged cognition or disappointing nerve symptoms.
Nerve-recovery stories	Interest includes nerve irritation and post-surgical recovery. A secondhand stroke-recovery story supplies no amount, route or medical records.

Notes

Clearer thinking without a dramatic buzz. Older accounts describe quieter mental noise, focus, stamina and stress composure. Sleep, expectations and other compounds can explain subjective changes.

Cognitive change can differ from symptom relief. A visual-snow reviewer described easier word retrieval and quicker thinking, but little visual improvement beyond slightly reduced afterimages. Cognitive change did not mean symptom resolution. Cortagen Review (Personal report · Accessed 2026-09-30)

Sleepiness can be the first noticeable experience. The first-use poster slept through the night and much of the day during a roughly five-day course. Exact after-dose latency was not reported. Is Cortagen peptide supposed to make you sleepy? (Personal report · Accessed 2026-09-30)

No response is part of the account. Historical reports include unchanged cognition and nerve-interest tracking of tingling, grip or symptom maps. They establish no success rate; easier thinking can coexist with disappointing symptom relief. Cortagen Review (Personal report · Accessed 2026-09-30)

Nerve recovery is an interest, not an established outcome. Historical interests include ulnar or sciatic irritation, post-surgical healing and neuropathy. A Reddit coworker stroke-recovery story describes better speech and balance, without dose, route or medical records. Peptide therapy — coworker stroke-recovery anecdote (Secondhand community claim · Accessed 2026-09-30)

Source context — Cortagen Review: Route, course length and onset missing. OP speculates about upwards of 20 mg/day without reporting having used it; excluded as a proposed escalation. Reply's targeting and cycling advice are unsupported.

Source context — Is Cortagen peptide supposed to make you sleepy?: Unverified product; route, baseline sleep, dose latency and dechallenge are absent. Visible thread only, not hidden/deleted replies.

Source context — Peptide therapy — coworker stroke-recovery anecdote: Secondhand report with no AEDP identity verification, dose, route, timing, medical confirmation or controls. Other users' BPC/Cortexin results do not count as Cortagen experiences.

Doses people talk about

0.5–2 mg once daily	Historical subcutaneous or intramuscular charts circulate this range; they are not human dose-finding studies.
4 mg/day; 4–6 mg/day	Separate first-person accounts report these daily totals with routes unstated. The 4 mg/day poster described pronounced sleepiness.
50 mcg per spray	One nasal-intended blend contained 50 mcg Cortagen, 50 mcg Pinealon and 250 mcg Epitalon per spray, initially tested sublingually. These are not daily totals.
Other chart claims	200–300 mcg/day, hearsay of 650 mcg–10 mg/day and a 5–10 mg every-other-day IM guide claim also circulate. Routes or human support are missing; oral and nasal amounts are not injection equivalents.

Notes

Historical injectable charts: 0.5–2 mg once daily. These subcutaneous or intramuscular charts are not human dose finding. Historical 200–400 mcg/day and 0.1–5 mg/day claims have unclear routes; do not merge them.

First-person daily totals: 4 mg; 4–6 mg. The sleepy poster used 4 mg/day for about five days; the visual-snow reviewer reported 4–6 mg/day. Both routes were unstated. These are separate experiences. Is Cortagen peptide supposed to make you sleepy? (Personal report · Accessed 2026-09-30) · Cortagen Review (Personal report · Accessed 2026-09-30)

Nasal blend: 50 mcg Cortagen per spray. Also 50 mcg Pinealon and 250 mcg Epitalon per spray: a nasal-intended blend initially tested sublingually. These are per-spray amounts, not daily totals. Pinealon and Cortagen — Nuke's mixed-peptide experiment (Personal report · Accessed 2026-09-30)

Lower numbers and higher claims still circulate. Reddit repeats 200–300 mcg daily and hearsay of 650 mcg–10 mg/day, routes unstated. Its guide's 5–10 mg every-other-day IM claim lacks clinical support. Historical 10 mcg/kg lore derives from rats. Cortagen — 2025 Complete Guide and replies (Secondhand community claim · Accessed 2026-09-30)

Oral and nasal figures need their own context. Historical oral capsules vary by brand; 0.1–1 mg nasal chart claims have uncertain absorption. Neither supplies an equivalent injection amount.

Source context — Pinealon and Cortagen — Nuke's mixed-peptide experiment: One uncontrolled mixed-peptide experiment with many supplements. Per-spray formulation is not a daily schedule. Attached score images not independently inspected; textual score claims only. No single-agent Cortagen inference.

Source context — Cortagen — 2025 Complete Guide and replies: Guide contains promotional-style vendor heading and extract-like clinical claims without supporting human studies. Replies repeat numbers rather than demonstrate use; route missing. Guide's alleged IM/IV hospital protocol is not authenticated.

Half-life, onset & duration

Felt onset	Historical clarity claims span days 4–10 or weeks 2–4; sleepiness appeared during one user's first five days.
Felt duration	No repeatable per-dose window is established. Historical claims of clarity lasting 2–4 weeks after a course remain reports, not measured persistence.
Half-life	Human half-life is unestablished in the saved record. A circulated 1–3-hour estimate has no supporting concentration-time study.

Notes

Early days may feel unchanged. The blend logger noticed no clear change within 48 hours. Historical clarity/composure claims span days 4–10 or weeks 2–4, alongside nothing-yet reports; routes were not preserved. Pinealon and Cortagen — Nuke's mixed-peptide experiment (Personal report · Accessed 2026-09-30)

No repeatable per-dose benefit window. Opened reports do not establish how many hours cognitive changes last. Course length and measured bodily half-life are separate questions. Cortagen Review (Personal report · Accessed 2026-09-30) · Is Cortagen peptide supposed to make you sleepy? (Personal report · Accessed 2026-09-30)

Two to four weeks after a course is residual-effect lore. Older accounts describe lingering clarity, symptom drift or gradual settling. These stories do not measure human persistence, plasma clearance or a dependable recovery window.

A circulated 1–3-hour claim is unverified. Peptide Reference supplies no supporting concentration-time study. Frontload says human half-life is unestablished. Neither guide measured clearance; generic minutes-scale peptide assumptions do not measure AEDP. Cortagen — Dosage, Half-Life & Research (Community guide · Accessed 2026-09-30) · What Is Cortagen? Dosage, Half-Life & How to Track It (Community guide · Accessed 2026-09-30)

Source context — Cortagen — Dosage, Half-Life & Research: Consumer guide with calculator links; its 1–3-hour estimate lacks an inspected underlying concentration-time study. Broad oral and injection amounts and Russian approval claim are not adopted as established facts.

Source context — What Is Cortagen? Dosage, Half-Life & How to Track It: Commercial app educational synthesis claims community protocols; no linked first-person dose cohort or human PK. Calculator and syringe instructions are outside this article. Not clinical guidance.

Cycles people discuss

Historical short courses	Charts discuss 10–20 days, sometimes 20–28, with 1–2-month breaks or 2–4 yearly courses. Nerve-interest 10–14-day blocks echo rat research.
Reported experiments	The sleepy account lasted about five days; the blend logger used it for about a month with missed or repeated days. A continuous-use reply provides no safety evidence.
Conflicting step-up charts	One commercial four-week chart uses 1 mg/day for two weeks, then 2 mg/day; an older chart steps up after one week. Neither establishes tolerability.

Notes

Historical blocks: 10–20 days; sometimes 20–28. Nerve-interest accounts use 10–14 days, echoing rat work. Charts mention 1–2-month breaks, at least eight weeks after longer blocks, or 2–4 yearly courses. These are conventions.

Actual experiments do not follow one calendar. Sleepy account: five days. Blend account: about a month, 3 mg total each Cortagen and Pinealon, missed/repeated days. A visual-snow reply favors continuous use without safety evidence. Is Cortagen peptide supposed to make you sleepy? (Personal report · Accessed 2026-09-30) · Pinealon and Cortagen — Nuke's mixed-peptide experiment (Personal report · Accessed 2026-09-30) · Cortagen Review (Personal report · Accessed 2026-09-30)

Commercial charts also differ. Frontload's four-week subcutaneous chart uses 1 mg/day for two weeks then 2 mg/day. The old chart steps up after one week. Neither establishes tolerability. What Is Cortagen? Dosage, Half-Life & How to Track It (Community guide · Accessed 2026-09-30)

Stacks

Pinealon and Epitalon	Historical accounts pair or rotate these with Cortagen, sometimes around two rotations yearly. The nasal-intended blend also contained both.
Semax or Selank	Historical stacks combine Cortagen with same-day focus or calm compounds. A dramatic clarity story also included Semax, Noopept and Adderall, so Cortagen's part is unclear.
Recovery and organ rotations	BPC-157, TB-500 and organ bioregulators appear in recovery stacks or yearly rotations. The record does not establish synergy or stimulant protection.

Notes

With Pinealon (EDR): Most common brain-bioregulator pair—same short course or adjacent blocks for cognition/longevity talk; multi-agent confound is high. [community]

With Epitalon (AEDG): Sequential or overlapping longevity courses; Epitalon framed as pineal/telomere-axis, Cortagen as cortex/nerve—complementary lore, not a proven synergy trial. [community]

Khavinson rotation: Cortagen → washout → Epitalon → washout → Pinealon (or similar order), ~2 rotations/year in educational stack pages. [community]

Semax / Selank adjacency: Cortagen as multi-week “substrate,” Semax (~300 mcg IN in some charts) or Selank (~250–500 mcg IN) as same-day acute focus/calm—different timescales, still confounded. [community]

A dramatic clarity story involved several changes. An illness-recovery account combines Cortagen, Semax, Noopept, other nootropics and 30 mg immediate-release Adderall. AEDP amount/route were unstated; recovery and concurrent agents prevent isolating its contribution. Peptides for healing brain after drug addiction? — Accurate_Tough8382 comment (Personal report · Accessed 2026-09-30)

BPC-157 ± TB-500 (recovery stack): Physique/nerve threads pair Cortagen’s axonal-growth narrative with BPC-157 (~250–500 mcg SubQ in common charts) soft-tissue/vascular repair for entrapment or post-surgical nerve talk. [community]

Broader organ cytogens: Yearly rotations sometimes include Cartalax, Livagen, Cardiogen, or other tissue bioregulators alongside cortex-directed AEDP. [community]

Rotations make attribution harder. Pinealon, Epitalon, Semax, Selank, BPC-157, TB-500 and organ bioregulators appear in historical stacks or roughly two yearly rotations. Synergy and protection during heavy stimulant use remain untested.

Source context — Peptides for healing brain after drug addiction? — Accurate_Tough8382 comment: Severe illness and spontaneous recovery, extreme prior stimulant discussion and concurrent agents confound all outcomes. No AEDP route/dose or reproducible two-day Cortagen onset.

Watch for

Sleep and tolerability	Drowsiness, flatness, headache, fatigue, nausea and light-headedness appear alongside evening activation and sleep-disruption warnings.
Injection risks	Reports and cautions include tenderness, redness, swelling, contamination and uncertain strength. Purity does not establish sterility.
Unmapped human safety	Long-term use, interactions, pregnancy and breastfeeding remain poorly mapped. Rat nerve and mouse findings do not establish human recovery or safety.

Notes

Sleep can move in either direction. Opened drowsiness and historical flatness, headache, fatigue, nausea or light-headedness reports coexist with roughly 2 mg evening activation/sleep-disruption warnings. Morning preference guarantees neither alertness nor sleep. Is Cortagen peptide supposed to make you sleepy? (Personal report · Accessed 2026-09-30)

Injected products add separate risks. Historical cautions include tenderness, redness, swelling, contamination and uncertain strength. Purity does not establish sterility; fever, spreading redness or allergic swelling are not signs of repair.

Repeated courses and stacks remain uncertain. Long-term safety, interactions, pregnancy, breastfeeding and serious neurological illness remain poorly mapped. “Bioregulator” does not establish freedom from adverse effects or justify replacing neurological care.

Rat nerve regeneration, not a human dose. The indexed 2000 abstract reports 10 mcg/kg intramuscularly for ten days after sciatic-nerve transection and suturing: growth rate and conduction velocity rose 27% and 40%. These are rat injury outcomes, not human recovery expectations. Turchaninova et al.: Effect of tetrapeptide cortagen on regeneration of sciatic nerve (Animal context · Accessed 2026-09-30)

Mouse behavior was dose dependent. Adriani's study tested 0.01, 0.03 and 0.10 mg/kg intraperitoneally. The middle dose increased movement with few anxiety-related changes; other doses showed anxiety-related effects after repeated treatment. The paper's broad reassuring conclusion should not become a human safety claim. Adriani et al.: Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice (Animal context · Accessed 2026-09-30)

Source context — Turchaninova et al.: Effect of tetrapeptide cortagen on regeneration of sciatic nerve: Primary abstract only; full paper is subscription access. No human subjects, half-life or plasma measurements. PubMed and Europe PMC article UI failed through web tool; API body succeeded through shell HTTPS.

Full notes

What Cortagen is

A defined peptide, different from Cortexin. AEDP joins alanine, glutamate, aspartate and proline in sequence. Cortexin is a peptide mixture; Cortagen is one synthetic sequence developed from that extract research. Extract clinical stories do not establish AEDP results. Animal context
“Bioregulator” describes the proposed idea. Discussion frames it as gradual tissue signaling. This does not prove cortex targeting, permanent brain repair or protection during stimulant or anabolic-steroid use. Community Community
Forms are not interchangeable. Historical discussion includes subcutaneous and intramuscular injections, variable-strength oral products and experimental nasal use. Their milligram amounts are not exposure-equivalent. Community

Benefits people seek

Clearer thinking without a dramatic buzz. Older accounts describe quieter mental noise, focus, stamina and stress composure. Sleep, expectations and other compounds can explain subjective changes. Community
Cognitive change can differ from symptom relief. A visual-snow reviewer described easier word retrieval and quicker thinking, but little visual improvement beyond slightly reduced afterimages. Cognitive change did not mean symptom resolution. Personal report
Nerve recovery is an interest, not an established outcome. Historical interests include ulnar or sciatic irritation, post-surgical healing and neuropathy. A Reddit coworker stroke-recovery story describes better speech and balance, without dose, route or medical records. Community Reddit, r/HPPD

Doses people discuss

Historical injectable charts: 0.5–2 mg once daily. These subcutaneous or intramuscular charts are not human dose finding. Historical 200–400 mcg/day and 0.1–5 mg/day claims have unclear routes; do not merge them. Community
First-person daily totals: 4 mg; 4–6 mg. The sleepy poster used 4 mg/day for about five days; the visual-snow reviewer reported 4–6 mg/day. Both routes were unstated. These are separate experiences. Personal report Personal report
Nasal blend: 50 mcg Cortagen per spray. Also 50 mcg Pinealon and 250 mcg Epitalon per spray: a nasal-intended blend initially tested sublingually. These are per-spray amounts, not daily totals. Personal report
Lower numbers and higher claims still circulate. Reddit repeats 200–300 mcg daily and hearsay of 650 mcg–10 mg/day, routes unstated. Its guide's 5–10 mg every-other-day IM claim lacks clinical support. Historical 10 mcg/kg lore derives from rats. Reddit, r/USPeptides Community
Oral and nasal figures need their own context. Historical oral capsules vary by brand; 0.1–1 mg nasal chart claims have uncertain absorption. Neither supplies an equivalent injection amount. Community

Half-life: measurements and claims

A circulated 1–3-hour claim is unverified. Peptide Reference supplies no supporting concentration-time study. Frontload says human half-life is unestablished. Neither guide measured clearance; generic minutes-scale peptide assumptions do not measure AEDP. Community guide Community guide Community

When people notice a change

Early days may feel unchanged. The blend logger noticed no clear change within 48 hours. Historical clarity/composure claims span days 4–10 or weeks 2–4, alongside nothing-yet reports; routes were not preserved. Personal report Community
Sleepiness can be the first noticeable experience. The first-use poster slept through the night and much of the day during a roughly five-day course. Exact after-dose latency was not reported. Personal report

How long reported effects last

No repeatable per-dose benefit window. Opened reports do not establish how many hours cognitive changes last. Course length and measured bodily half-life are separate questions. Personal report Personal report
Two to four weeks after a course is residual-effect lore. Older accounts describe lingering clarity, symptom drift or gradual settling. These stories do not measure human persistence, plasma clearance or a dependable recovery window. Community Community

Courses and breaks people describe

Historical blocks: 10–20 days; sometimes 20–28. Nerve-interest accounts use 10–14 days, echoing rat work. Charts mention 1–2-month breaks, at least eight weeks after longer blocks, or 2–4 yearly courses. These are conventions. Community
Actual experiments do not follow one calendar. Sleepy account: five days. Blend account: about a month, 3 mg total each Cortagen and Pinealon, missed/repeated days. A visual-snow reply favors continuous use without safety evidence. Personal report Personal report Personal report
Commercial charts also differ. Frontload's four-week subcutaneous chart uses 1 mg/day for two weeks then 2 mg/day. The old chart steps up after one week. Neither establishes tolerability. Community guide Community

Adverse reports and safety limits

Sleep can move in either direction. Opened drowsiness and historical flatness, headache, fatigue, nausea or light-headedness reports coexist with roughly 2 mg evening activation/sleep-disruption warnings. Morning preference guarantees neither alertness nor sleep. Personal report Community Community
Injected products add separate risks. Historical cautions include tenderness, redness, swelling, contamination and uncertain strength. Purity does not establish sterility; fever, spreading redness or allergic swelling are not signs of repair. Community
Repeated courses and stacks remain uncertain. Long-term safety, interactions, pregnancy, breastfeeding and serious neurological illness remain poorly mapped. “Bioregulator” does not establish freedom from adverse effects or justify replacing neurological care. Community

What the animal research contributes

Rat nerve regeneration, not a human dose. The indexed 2000 abstract reports 10 mcg/kg intramuscularly for ten days after sciatic-nerve transection and suturing: growth rate and conduction velocity rose 27% and 40%. These are rat injury outcomes, not human recovery expectations. Animal context
Gene changes were measured in mouse heart. The 2004 microarray study identified altered expression in 110 known genes after five days. A cardiac-tissue result does not establish a cortex-specific human effect or a measured half-life. Animal context
Mouse behavior was dose dependent. Adriani's study tested 0.01, 0.03 and 0.10 mg/kg intraperitoneally. The middle dose increased movement with few anxiety-related changes; other doses showed anxiety-related effects after repeated treatment. The paper's broad reassuring conclusion should not become a human safety claim. Animal context

From community discussion

Improvement on one task did not mean improvement everywhere. The blend logger described better Stroop/rotation performance but unchanged reaction time and working memory. Supplements and repeat testing prevent isolating Cortagen. Personal report
A dramatic clarity story involved several changes. An illness-recovery account combines Cortagen, Semax, Noopept, other nootropics and 30 mg immediate-release Adderall. AEDP amount/route were unstated; recovery and concurrent agents prevent isolating its contribution. Personal report
No response is part of the account. Historical reports include unchanged cognition and nerve-interest tracking of tingling, grip or symptom maps. They establish no success rate; easier thinking can coexist with disappointing symptom relief. Community Personal report
Rotations make attribution harder. Pinealon, Epitalon, Semax, Selank, BPC-157, TB-500 and organ bioregulators appear in historical stacks or roughly two yearly rotations. Synergy and protection during heavy stimulant use remain untested. Community Community